26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
The US Court of Appeals for the Federal Circuit held that notwithstanding a stipulation on claim con...
Read More >
Minnesota’s wage theft law, which largely went into effect on July 1, 2019, created new documentati...
Read More >
Read the latest news on antitrust, competition and economic regulation (ACER) in this Spring's editi...
Read More >
A recent decision of the North Carolina Court of Appeals serves as an important reminder to avoid th...
Read More >
Lean construction aims to minimize waste of materials, time and effort and increase the productivity...
Read More >
In the UK, the definition of "worker" includes both employees and anyone else working under a contra...
Read More >